Arcus Biosciences, Inc. — Director's Dealing 2019

May 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2019-04-29

Reporting Person: Grossman William (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-29	Stock Option (right to buy)	$10.49	A	400000	Acquired	2029-04-28	Common Stock (400000)	Direct

Footnotes

F1: The option is exercisable in 48 equal monthly installments after April 29, 2019, subject to the Reporting Person's continued service to the Company.